Cargando…

Using continuous data on tumour measurements to improve inference in phase II cancer studies

Detalles Bibliográficos
Autores principales:	Wason, James, Seaman, Shaun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980231/ http://dx.doi.org/10.1186/1745-6215-14-S1-O116

Ejemplares similares

Using continuous data on tumour measurements to improve inference in phase II cancer studies
por: Wason, James MS, et al.
Publicado: (2013)

Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
por: Lin, Chien-Ju, et al.
Publicado: (2015)

Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements
por: Lin, Chien‐Ju, et al.
Publicado: (2017)

The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected
por: Wason, James MS, et al.
Publicado: (2015)

Optimal design for multi-arm multi-stage clinical trials
por: Wason, James MS, et al.
Publicado: (2011)

Inferring the evolutionary history of Populus trichocarpa from whole genome resequencing data
por: DiFazio, Stephen, et al.
Publicado: (2011)

An adaptive biomarker strategy clinical trial design
por: Wason, James, et al.
Publicado: (2013)

Using meta-analysis of Phase II trials to predict Phase III trial results
por: Burke, Danielle, et al.
Publicado: (2013)

Pediatric tumours: liver tumours
por: Towbin, Alexander J
Publicado: (2014)

S128: CONTINUOUS QUALITY IMPROVEMENT IN PAEDIATRIC SICKLE CELL DISEASE
por: Ahemad, E, et al.
Publicado: (2022)

Pediatric tumours: pseudotumour or a tumour?
por: Huisman, Thierry AGM
Publicado: (2014)

Multimodal hand hygiene program: twelve years of continuous improvement in the hospital
por: Kawagoe, JY, et al.
Publicado: (2015)

A series of decision-theoretic phase II trials of related treatments
por: Hee, Siew Wan, et al.
Publicado: (2013)

Combining pharmacophore- and MD-based modelling for phase II metabolism prediction
por: Rakers, Christin, et al.
Publicado: (2014)

Comparing active treatments at phase II: using multiple criteria to find the optimal treatment to take forward to phase III
por: Sweeting, Michael, et al.
Publicado: (2013)

Orbital tumours
por: Chong, Vincent
Publicado: (2015)

S122: SAFETY AND EFFICACY OF CRIZANLIZUMAB IN ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): INITIAL DATA FROM THE PHASE II, MULTICENTER, OPEN-LABEL SOLACE-KIDS TRIAL
por: Heeney, M, et al.
Publicado: (2022)

Tumour-selective transcriptional targeting for breast cancer gene therapy
por: Hurst, HC
Publicado: (2000)

Design choices for small-scale phase II trials with non-inferiority (NI) intention
por: Sun, Hong, et al.
Publicado: (2011)

Preliminary results from a Phase I/II study of epacadostat (incb024360) in combination with pembrolizumab in patients with selected advanced cancers
por: Gangadhar, Tara C, et al.
Publicado: (2015)

OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector
por: Baden, LR, et al.
Publicado: (2009)

First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine
por: Walsh, SR, et al.
Publicado: (2012)

Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia
por: Yap, Christina, et al.
Publicado: (2011)

The pathology of inherited breast tumours
por: Stratton, M
Publicado: (2000)

Imaging tumour response - challenges
por: Rasmussen, Finn
Publicado: (2015)

Trial-by-trial modeling of electrophysiological signals during inverse Bayesian inference
por: Kolossa, Antonio, et al.
Publicado: (2014)

An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
por: Stallard, Nigel
Publicado: (2011)

A Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritis
por: Whitehead, Anne, et al.
Publicado: (2011)

Inferred network from prefrontal cortex activity of rats unveils cell assemblies
por: Tavoni, Gaia, et al.
Publicado: (2013)

Novel roles for integrins in tumour angiogenesis
por: Germain, M, et al.
Publicado: (2006)

Imaging tumour response: beyond RECIST
por: Koh, Dow-Mu
Publicado: (2014)

PRECIS-2: a tool to improve the applicability of randomised controlled trials
por: Loudon, Kirsty, et al.
Publicado: (2013)

Making continuous outcomes meaningful to clinicians
por: Peacock, Janet L, et al.
Publicado: (2011)

Role of molecular imaging in the detection of neuroendocrine tumour
por: Wild, Damian
Publicado: (2014)

Theranostics: radionuclide imaging and therapy in neuroendocrine tumours
por: Drake, Brent, et al.
Publicado: (2015)

Phase II investigation of a PARP inhibitor (olaparib) in castration resistant prostate cancer (CRPC) which incorporates the possibility that treatment effect may be restricted to biomarker defined subgroups
por: A’Hern, Roger, et al.
Publicado: (2011)

Continuous Monitoring of Urine Output And Hemodynamic Disturbances Improves Early Detection of Acute Kidney Injury During First Week of Icu Stay
por: Flechet, M, et al.
Publicado: (2015)

Improving the accuracy of cardiac DTI by averaging the complex data
por: Scott, Andrew D, et al.
Publicado: (2015)

Continuous suture technique in aortic valve replacement
por: Panagiotopoulos, I, et al.
Publicado: (2013)

The continuous race of therapy optimization in sepsis control
por: Iovănescu, Doina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fjfermclljbjdcfusu9a92k56p